Nuveen’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.8M | Sell |
|
|||||
|
2025
Q1 | $31.7M | Buy |
|
|||||
|
2024
Q4 | $36.6M | Sell |
|
|||||
|
2024
Q3 | $39.8M | Sell |
|
|||||
|
2024
Q2 | $47.8M | Sell |
|
|||||
|
2024
Q1 | $49.3M | Sell |
|
|||||
|
2023
Q4 | $47.5M | Sell |
|
|||||
|
2023
Q3 | $41.1M | Buy |
|
|||||
|
2023
Q2 | $30.6M | Buy |
|
|||||
|
2023
Q1 | $24.7M | Sell |
|
|||||
|
2022
Q4 | $29.6M | Sell |
|
|||||
|
2022
Q3 | $26.3M | Sell |
|
|||||
|
2022
Q2 | $24.8M | Buy |
|
|||||
|
2022
Q1 | $23.5M | Buy |
|
|||||
|
2021
Q4 | $20.9M | Sell |
|
|||||
|
2021
Q3 | $26.7M | Sell |
|
|||||
|
2021
Q2 | $35.6M | Sell |
|
|||||
|
2021
Q1 | $43.8M | Sell |
|
|||||
|
2020
Q4 | $44.7M | Sell |
|
|||||
|
2020
Q3 | $53.5M | Sell |
|
|||||
|
2020
Q2 | $71.9M | Sell |
|
|||||
|
2020
Q1 | $53.8M | Sell |
|
|||||
|
2019
Q4 | $74.4M | Sell |
|
|||||
|
2019
Q3 | $72.8M | Buy |
|
|||||
|
2019
Q2 | $64.7M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $626K | Buy |
|
|||||
|
2016
Q4 | $530K | Hold |
|
|||||
|
2016
Q3 | $694K | Buy |
|
|||||
|
2016
Q2 | $498K | Sell |
|
|||||
|
2016
Q1 | $1.33K | Sell |
|
|||||
|
2015
Q4 | $2.2K | Buy |
|
|||||
|
2015
Q3 | $1.22K | Sell |
|
|||||
|
2015
Q2 | $1.78K | Buy |
|
|||||
|
2015
Q1 | $1.42M | Buy |
|